Riverhead Capital Management’s Natus Medical Inc NTUS Stock Holding History

Riverhead Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$154K	Hold	4,837	–	–	0.01%	1216
2019 Q2	$124K	Hold	4,837	–	–	﹤0.01%	1290
2019 Q1	$123K	Hold	4,837	–	–	0.01%	1280
2018 Q4	$165K	Buy	4,837 +200	+4%	+$6.5K	0.01%	1153
2018 Q3	$165K	Buy	4,637 +800	+21%	+$28.2K	0.01%	1263
2018 Q2	$132K	Hold	3,837	–	–	0.01%	1259
2018 Q1	$129K	Hold	3,837	–	–	0.01%	1257
2017 Q4	$147K	Buy	3,837 +600	+19%	+$24K	0.01%	1206
2017 Q3	$121K	Buy	3,237 +373	+13%	+$13.2K	0.01%	1213
2017 Q2	$107K	Buy	2,864 +1,364	+91%	+$49.3K	0.01%	1194
2017 Q1	$59K	Hold	1,500	–	–	﹤0.01%	1218
2016 Q4	$52K	Hold	1,500	–	–	﹤0.01%	1228
2016 Q3	$59K	Sell	1,500 -117,960	-99%	-$4.7M	﹤0.01%	1129
2016 Q2	$4.02M	Buy	119,460 +112,684	+1,663%	+$3.77M	0.13%	212
2016 Q1	$260K	Sell	6,776 -924	-12%	-$34.4K	﹤0.01%	1163
2015 Q4	$370K	Buy	7,700 +5,000	+185%	+$231K	0.01%	1043
2015 Q3	$107K	Buy	+2,700	New	+$115K	﹤0.01%	1061

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Riverhead Capital Management's NTUS Position: Q3 2019 in Review

Riverhead Capital Management held its Natus Medical Inc (NTUS) position steady in Q3 2019 at 4,837 shares worth $154K. The position accounts for 0.01% of the portfolio, ranked #1216.

Riverhead Capital Management first reported a position in NTUS in Q3 2015 and has held it in 17 quarters since. The position peaked at $4.02M in Q2 2016. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

Riverhead Capital Management held 4,837 shares of Natus Medical Inc worth $154K as of Q3 2019.
Riverhead Capital Management left its Natus Medical Inc share count unchanged in Q3 2019.
Natus Medical Inc made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1216 holding.
Riverhead Capital Management first reported a position in Natus Medical Inc in Q3 2015 and has held it in 17 quarters since.
Riverhead Capital Management's Natus Medical Inc position peaked at $4.02M in Q2 2016.
168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.